Menu
Search
|

Menu

Close
X

Daiichi Sankyo Co Ltd 4568.T (Tokyo Stock Exchange)

3,885.00 JPY
+47.00 (+1.22%)
As of 11:30 AM IST
chart
Previous Close 3,838.00
Open 3,848.00
Volume 1,691,700
3m Avg Volume 2,609,444
Today’s High 3,900.00
Today’s Low 3,843.00
52 Week High 4,241.00
52 Week Low 2,284.50
Shares Outstanding (mil) 709.01
Market Capitalization (mil) 1,772,528.00
Forward P/E 32.24
Dividend (Yield %) 35.00 ( 2.80 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.83 Mean rating from 12 analysts

KEY STATS

Revenue (mm, JPY)
FY18
741,047
FY17
955,123
FY16
986,446
FY15
775,601
EPS (JPY)
FY18
109.362
FY17
78.371
FY16
118.308
FY15
19.569
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
32.24
32.90
Price to Sales (TTM)
vs sector
1.86
5.77
Price to Book (MRQ)
vs sector
1.39
5.41
Price to Cash Flow (TTM)
vs sector
18.99
23.42
Total Debt to Equity (MRQ)
vs sector
24.62
16.52
LT Debt to Equity (MRQ)
vs sector
24.58
12.22
Return on Investment (TTM)
vs sector
2.97
14.43
Return on Equity (TTM)
vs sector
4.38
16.13

EXECUTIVE LEADERSHIP

Joji Nakayama
Chairman of the Board, Chief Executive Officer, Representative Director, Since 2017
Salary: --
Bonus: --
Sunao Manabe
Executive President, President, Chief Operating Officer, Representative Director, Since 2017
Salary: --
Bonus: --
Kazunori Hirokawa
Executive Vice President, Vice President, Chief Financial Officer, Representative Director, Since 2017
Salary: --
Bonus: --
Kentaro Takamura
Executive Officer, Director of Finance & Accounting in Main Business Strategy Unit, Since 2017
Salary: --
Bonus: --
Satoru Kimura
Senior Managing Executive Officer, Chief Director of Medicine Sales, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Daiichi Sankyo Bldg. A/B Kan
3-5-1, Nihombashi Hon-cho
CHUO-KU   TKY   103-8426

Phone: +813.62251111

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe, China and Brazil markets. As of March 31, 2014, it had 100 subsidiaries and four associated companies.

SPONSORED STORIES